98.84
2.39%
+2.4597
ICU Medical, Inc. stock is currently priced at $98.84, with a 24-hour trading volume of 13,259.
It has seen a +2.39% increased in the last 24 hours and a +0.59% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $95.80 pivot point. If it approaches the $99.73 resistance level, significant changes may occur.
ICU Medical, Inc. Stock (ICUI) Financials Data
ICU Medical, Inc. (ICUI) Revenue 2024
ICUI reported a revenue (TTM) of $2.26 billion for the quarter ending December 31, 2023, a -0.92% decline year-over-year.
ICU Medical, Inc. (ICUI) Net Income 2024
ICUI net income (TTM) was -$29.66 million for the quarter ending December 31, 2023, a +60.08% increase year-over-year.
ICU Medical, Inc. (ICUI) Cash Flow 2024
ICUI recorded a free cash flow (TTM) of $72.53 million for the quarter ending December 31, 2023, a +144.92% increase year-over-year.
ICU Medical, Inc. (ICUI) Earnings per Share 2024
ICUI earnings per share (TTM) was -$1.23 for the quarter ending December 31, 2023, a +60.58% growth year-over-year.
ICU Medical, Inc. Stock (ICUI) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Woolson Daniel | VP, GM-Infusion Capital |
Mar 15 '24 |
Option Exercise |
0.00 |
2,923 |
0 |
16,903 |
Sousa Ben | Chief Information Officer |
Mar 15 '24 |
Option Exercise |
0.00 |
1,299 |
0 |
3,782 |
Sanzone Virginia Ruth | VP, General Counsel |
Mar 15 '24 |
Option Exercise |
0.00 |
1,624 |
0 |
7,422 |
Jain Vivek | Chairman and CEO |
Mar 15 '24 |
Option Exercise |
0.00 |
4,871 |
0 |
107,264 |
Bonnell Brian Michael | Chief Financial Officer |
Mar 15 '24 |
Option Exercise |
0.00 |
3,247 |
0 |
26,734 |
Woolson Daniel | VP, GM-Infusion Capital |
Mar 15 '24 |
Sale |
98.27 |
791 |
77,733 |
13,980 |
LOPEZ GEORGE A | Director |
Mar 14 '24 |
Sale |
101.87 |
7,978 |
812,741 |
877,343 |
LOPEZ GEORGE A | Director |
Mar 12 '24 |
Sale |
101.51 |
1,522 |
154,497 |
316,231 |
LOPEZ GEORGE A | Director |
Mar 11 '24 |
Sale |
104.22 |
1,890 |
196,968 |
317,753 |
Sousa Ben | Chief Information Officer |
Mar 08 '24 |
Option Exercise |
0.00 |
674 |
0 |
2,723 |
ICU Medical, Inc. Stock (ICUI) Latest News
ICU Medical Announces Time of First Quarter 2024 Earnings Conference Call
GlobeNewswire Inc.
ICU Medical to Present at the KeyBanc Life Sciences & MedTech Investor Forum
GlobeNewswire Inc.
ICU Medical to Present at the Raymond James 45ᵗʰ Annual Institutional Investors Conference
GlobeNewswire Inc.
Zacks.com featured highlights include ICU Medical and Ardmore Shipping
Zacks Investment Research
ICU Medical To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Wednesday
Benzinga
ICU Medical (ICUI) Q4 Earnings and Revenues Surpass Estimates
Zacks Investment Research
About ICU Medical, Inc.
ICU Medical, Inc. develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave, and NanoClave brands; Neutron catheter patency connectors; SwabCap disinfecting caps; Tego hemodialysis connectors; NovaCath and SuperCath peripheral intravenous (IV) catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV solutions, such as normal salines, ringers, etc., which are used to replenish fluids and electrolytes; irrigation solutions to hydrate the wound, remove deep debris, assist with visual examination, to prevent infection, and improve healing; and nutritional solutions that feed vitamins, minerals, and other natural therapeutic substances directly into the blood stream. In addition, the company offers infusion pumps under the Plum 360, LifeCare PCA, SapphirePlus, and Sapphire names; Cogent 2-in-1 and LiDCO LX1 hemodynamic monitoring systems; CardioFlo hemodynamic monitoring sensors; TriOx PICC invasive venous oximetry sensors; SafeSet closed blood sampling and conservation systems; Transpac consumable blood pressure transducers; and Q2 Plus continuous cardiac output/oximetry systems. The company sells its products primarily to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.
Cap:
|
Volume (24h):